CDC Recommends Pediatric COVID-19 Vaccine for Children 5 to 11 Years | CDC Online Newsroom | CDC
https://www.cdc.gov/media/releases/2021/s1102-PediatricCOVID-19Vaccine.html
https://www.cdc.gov/media/releases/2021/s1102-PediatricCOVID-19Vaccine.html
Centers for Disease Control and Prevention
Coronavirus Disease 2019
CDC provides credible COVID-19 health information to the U.S.
No, the COVID-19 vaccines don’t affect fertility | American Medical Association
https://www.ama-assn.org/delivering-care/public-health/no-covid-19-vaccines-don-t-affect-fertility
https://www.ama-assn.org/delivering-care/public-health/no-covid-19-vaccines-don-t-affect-fertility
American Medical Association
No, the COVID-19 vaccines don’t affect fertility
Concerns about fertility, pregnancy are among the six myths and misconceptions that hold patients back from vaccination. Learn more with the AMA.
Frequently Asked Questions: COVID-19 and Diabetes | ADA
https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes
https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes
diabetes.org
Frequently Asked Questions: COVID-19 and Diabetes | ADA
Are people with diabetes at higher risk from COVID-19? What precautions should you be taking? Is it safe to work? Find answers to all your questions.
A record 100,000 overdose deaths in 12 months, driven by opioids, fentanyl - The Washington Post
https://www.washingtonpost.com/health/2021/11/17/overdose-deaths-pandemic-fentanyl/
https://www.washingtonpost.com/health/2021/11/17/overdose-deaths-pandemic-fentanyl/
Original research: External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595052/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595052/
PubMed Central (PMC)
Original research: External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality…
The QCovid algorithm is a risk prediction tool that can be used to stratify individuals by risk of COVID-19 hospitalisation and mortality. Version 1 of the algorithm was trained using data covering 10.5 million patients in England in the period ...
On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern and has named it Omicron
https://www.cdc.gov/media/releases/2021/s1126-B11-529-omicron.html
https://www.cdc.gov/media/releases/2021/s1126-B11-529-omicron.html
https://www.cdc.gov/media/releases/2021/s1126-B11-529-omicron.html
https://www.cdc.gov/media/releases/2021/s1126-B11-529-omicron.html
Coronavirus: What's happening in Canada and around the world on Sunday
https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-nov28-2021-1.6265706
https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-nov28-2021-1.6265706
CBC
Dutch officials confirm 13 cases of omicron variant as travel rules tighten around the world | CBC News
More omicron infections were reported around the world on Sunday, with 13 cases of the new coronavirus variant found in the Netherlands and two in Australia, as more countries tried to seal themselves off by imposing travel restrictions.
What's New | COVID-19 Treatment Guidelines
https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new/
https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new/
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - The Lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02717-3/fulltext
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02717-3/fulltext
EUA 91 HCP FS_Omicron 12_22_2021 Final.pdf
479.2 KB
EUA 91 HCP FS_Omicron 12_22_2021 Final.pdf
Paxlovid, is most effective when taken during the early stages of COVID-19,
Recommending it be used within five days of the first symptoms.https://www.reuters.com/world/uk/britain-approves-pfizer-covid-19-pill-2021-12-31/
Recommending it be used within five days of the first symptoms.https://www.reuters.com/world/uk/britain-approves-pfizer-covid-19-pill-2021-12-31/
Reuters
Britain approves Pfizer's antiviral COVID-19 pill
Britain has approved Pfizer's COVID-19 pill for adults who have mild to moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus.
"Coadministration of COVID-19 vaccines with other vaccines
COVID-19 vaccines may be administered without regard to timing of other vaccines.
This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day. If multiple vaccines are administered at a single visit, administer each injection in a different injection site. For people ≥11 years of age, the deltoid muscle can be used for more than one intramuscular injection administered at different sites in the muscle. For children (5–10 years of age), if more than two vaccines are injected in a single limb, the vastus lateralis muscle of the anterolateral thigh is the preferred site because of greater muscle mass.
Best practices for multiple injections include:
Label each syringe with the name and the dosage (amount) of the vaccine, lot number, the initials of the preparer, and the exact beyond-use time, if applicable.
Separate injection sites by 1 inch or more, if possible.
Administer the COVID-19 vaccine and vaccines that may be more likely to cause a local reaction in different limbs, if possible.
See general best practices and Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) for further information."
https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#:~:text=Coadministration%20of%20COVID,for%20further%20information.
COVID-19 vaccines may be administered without regard to timing of other vaccines.
This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day. If multiple vaccines are administered at a single visit, administer each injection in a different injection site. For people ≥11 years of age, the deltoid muscle can be used for more than one intramuscular injection administered at different sites in the muscle. For children (5–10 years of age), if more than two vaccines are injected in a single limb, the vastus lateralis muscle of the anterolateral thigh is the preferred site because of greater muscle mass.
Best practices for multiple injections include:
Label each syringe with the name and the dosage (amount) of the vaccine, lot number, the initials of the preparer, and the exact beyond-use time, if applicable.
Separate injection sites by 1 inch or more, if possible.
Administer the COVID-19 vaccine and vaccines that may be more likely to cause a local reaction in different limbs, if possible.
See general best practices and Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) for further information."
https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#:~:text=Coadministration%20of%20COVID,for%20further%20information.
Covid
Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States
Links to interim clinical considerations on use of COVID-19 vaccines, recent changes, and resources
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-multiple-actions-expand-use-pfizer-biontech-covid-19-vaccine
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-multiple-actions-expand-use-pfizer-biontech-covid-19-vaccine
https://www.nejm.org/doi/full/10.1056/NEJMoa2116044 Early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, un vaccinated adults with Covid-19
NEJM
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute res...